Hvivo PLC (LON:HVO) insider Trevor Phillips bought 9,035 shares of Hvivo stock in a transaction that occurred on Thursday, December 14th. The shares were acquired at an average price of GBX 56 ($0.75) per share, with a total value of £5,059.60 ($6,809.69).

Shares of Hvivo PLC (LON HVO) opened at GBX 54 ($0.73) on Friday. Hvivo PLC has a 1-year low of GBX 50 ($0.67) and a 1-year high of GBX 239.75 ($3.23).

Hvivo (LON:HVO) last issued its earnings results on Thursday, September 21st. The company reported GBX (9.90) (($0.13)) earnings per share for the quarter. The business had revenue of GBX 392 million for the quarter. Hvivo had a negative return on equity of 36.48% and a negative net margin of 196.81%.

Separately, Numis Securities cut shares of Hvivo to a “hold” rating and set a GBX 80 ($1.08) target price for the company. in a report on Thursday, September 21st.

ILLEGAL ACTIVITY NOTICE: “Hvivo PLC (HVO) Insider Trevor Phillips Purchases 9,035 Shares” was first reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another domain, it was stolen and reposted in violation of US & international trademark & copyright laws. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/12/14/hvivo-plc-hvo-insider-trevor-phillips-purchases-9035-shares.html.

Hvivo Company Profile

hVIVO plc, formerly Retroscreen Virology Group plc, is a holding company. The Company is engaged in a life sciences business pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, respiratory syncytial virus (RSV), asthma and common cold.

Receive News & Ratings for Hvivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hvivo and related companies with MarketBeat.com's FREE daily email newsletter.